ARCHIVES

NCI to Implement More Transparent Formula For Calculating Cancer Center Support Grants

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

DCE Advisors approver New Grant Programs In Ovarian Cancer, Biostatistics, Biotech Transfer; Support Services Recompetitions

June 19, 1992

Cancer Care Uneven, IOM’s National Cancer Policy Board Concludes

April 9, 1999

US Oncology To Participate In Firm’s Ovarian Cancer Trial.

January 26, 2001

NCI T BE More Flexible In Funding RFAs Above Paylines

June 23, 1989

Stand Up To Cancer Launches Immunology “Dream Team”

December 14, 2012

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004